Coding

Part:BBa_K3712001:Design

Designed by: Yifan Li   Group: iGEM21_HUST2-China   (2021-10-01)


Bombinin-like peptide 7 (BLP-7)


Assembly Compatibility:
  • 10
    INCOMPATIBLE WITH RFC[10]
    Illegal PstI site found at 26
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal PstI site found at 26
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    INCOMPATIBLE WITH RFC[23]
    Illegal PstI site found at 26
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal PstI site found at 26
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

Bombinin-like peptide 7 (BLP-7), which was determined from Bombina orientalis, has been shown to possess certain antibacterial activity. Study shows that 5μM of it inhibits P. acnes’ growth in vitro[1]. It is an antimicrobial peptide consisting of 27 amino acids and has been shown to have a broad spectrum of antibacterial activity. Cell experiments showed that BLP-7 inhibits the expression of two proinflammatory cytokines IL-8 and granulocyt-macrophage colony-stimulating factor (GM-CSF) in normal human epidermal keratinocytes (NHEKs), and had anti-inflammatory effects[2]. The secondary structure of BLP-7 is a cationic amphiphilic α helix, which can target the lipid bilayer of bacterial cell plasma membrane, punch holes through the membrane and kill bacteria.

Source

This gene fragment was synthesized in GenScript.

References

[1] Yun Wu, Yuanyuan Qiang, Kun Cao, Wei Zhang, Guangxian Zhang,Inhibitory effect of the antimicrobial peptide BLP-7 against Propionibacterium acnes and its anti-inflammatory effect on acne vulgaris,Toxicon,Volume 184,2020,Pages 109-115, [2] Wu Y, Qiang Y, Cao K, et al. Inhibitory effect of the antimicrobial peptide BLP-7 against Propionibacterium acnes and its anti-inflammatory effect on acne vulgaris. Toxicon. 2020;184:109-115.